Inj tisotu vedotin-tftv, 1mg
Products billed under this code include Tivdak.
Payment limit per 1 MG, by effective quarter, 3Q22 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Tivdak.
Payment limit per 1 MG, by effective quarter, 3Q22 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Tivdak | Pfizer Inc | 51144-0003-01 | 40 | $7,844.84 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $196.121 | $0.00 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted September 17, 2026 |
| 3Q26 | $196.121 | $0.00 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted September 15, 2026 |
| 2Q26 | $196.121 | +$0.053 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted September 15, 2026 |
| 1Q26 | $196.068 | +$7.308 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted September 15, 2026 |
| 4Q25 | $188.76 | +$0.112 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted September 8, 2026 |
| 3Q25 | $188.648 | −$0.003 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted March 10, 2026 |
| 2Q25 | $188.651 | +$6.777 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted March 10, 2026 |
| 1Q25 | $181.874 | +$0.276 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted December 19, 2025 |
| 4Q24 | $181.598 | +$6.651 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted June 11, 2025 |
| 3Q24 | $174.947 | +$0.148 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted June 11, 2025 |
| 2Q24 | $174.799 | +$6.489 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted March 11, 2025 |
| 1Q24 | $168.31 | +$0.048 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted December 19, 2024 |
| 4Q23 | $168.262 | +$6.211 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted October 10, 2024 |
| 3Q23 | $162.051 | +$0.09 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted June 5, 2024 |
| 2Q23 | $161.961 | +$5.964 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted February 23, 2024 |
| 1Q23 | $155.997 | +$0.094 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted December 6, 2023 |
| 4Q22 | $155.903 | −$0.005 | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted June 22, 2023 |
| 3Q22 | $155.908 | – | 1 MG | Inj tisotu vedotin-tftv, 1mg | v1, posted June 9, 2023 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.